Among the researchers at the Cancer Center are three groups: basic scientists, translational researchers and clinical researchers. The basic scientists compare normal and abnormal cells, identifying and validating targets for drug intervention in vitro and in animal models. Translational researchers look for new investigational drugs and design human trials. The clinical researchers conduct Phase I, II and III trials with patients. These scientists and physician scientists work collaboratively.
Farrukh T. Awan, MD Cancer Immunology and Immunotherapy
E. Gerald Bennett, PhD Cancer Prevention & Control

Developmental Therapeutics, Head and Neck Cancer Multidisciplinary Taskforce,
Thoracic Oncology Research Group, Pathologist

Molecular Oncology Program, Molecular Signaling; Institute of Molecular Medicine and Genetics
Jimmy J. Brown, MDDevelopmental Therapeutics
Darren Browning, PhDMolecular Oncology Program, Molecular Signaling
Phillip Joe Buckhaults, PhDMolecular Oncology Program, Genomics / Epigenomics
Anil G. Cashikar, PhDMolecular Oncology Program, Chaperone Biology
Center for Molecular Chaperones, Radiobiology and Cancer Virology
Ahmed Chadli, PhDMolecular Oncology Program, Chaperone Biology
Center for Molecular Chaperones, Radiobiology and Cancer Virology
Phillip Chandler, PhDCancer Immunology and Immunotherapy
Paul Dainer, MD Cancer Prevention & Control
Quansheng Du, PhD, DScDevelopmental Therapeutics
William Dynan, PhDMolecular Oncology Program
Ali Eroglu, PhD, DVMMolecular Oncology Program
